146 related articles for article (PubMed ID: 1597127)
1. Acetylcholinesterase inhibition and anti-soman efficacy of homologs of physostigmine.
Harris LW; Anderson DR; Pastelak AM; Bowersox SL; Vanderpool BA; Lennox WJ
Drug Chem Toxicol; 1992; 15(2):127-43. PubMed ID: 1597127
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
Harris LW; Anderson DR; Pastelak AM; Vanderpool B
Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
[TBL] [Abstract][Full Text] [Related]
3. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
Lennox WJ; Harris LW; Talbot BG; Anderson DR
Life Sci; 1985 Sep; 37(9):793-8. PubMed ID: 4033355
[TBL] [Abstract][Full Text] [Related]
4. Effects of subacute administration of physostigmine on blood acetylcholinesterase activity, motor performance, and soman intoxication.
Harris LW; Anderson DR; Lennox WJ; Solana RP
Toxicol Appl Pharmacol; 1989 Feb; 97(2):267-71. PubMed ID: 2922758
[TBL] [Abstract][Full Text] [Related]
5. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
Wetherell JR
J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
[TBL] [Abstract][Full Text] [Related]
6. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs.
Philippens IH; Melchers BP; Olivier B; Bruijnzeel PL
Pharmacol Biochem Behav; 2000 Jan; 65(1):175-82. PubMed ID: 10638651
[TBL] [Abstract][Full Text] [Related]
7. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects.
Philippens IH; Busker RW; Wolthuis OL; Olivier B; Bruijnzeel PL; Melchers BP
Pharmacol Biochem Behav; 1998 Apr; 59(4):1061-7. PubMed ID: 9586868
[TBL] [Abstract][Full Text] [Related]
8. Oxime-induced decarbamylation and atropine/oxime therapy of guinea pigs intoxicated with pyridostigmine.
Harris LW; Talbot BG; Anderson DR; Lennox WJ; Green MD
Life Sci; 1987 Feb; 40(6):577-83. PubMed ID: 3807651
[TBL] [Abstract][Full Text] [Related]
9. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
Cho Y; Kim WS; Hur GH; Ha YC
Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
[TBL] [Abstract][Full Text] [Related]
10. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antidotes against soman poisoning in female physostigmine-protected rats.
Sket D
Pharmacol Toxicol; 1993 Jan; 72(1):25-30. PubMed ID: 8441737
[TBL] [Abstract][Full Text] [Related]
12. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
Herkert NM; Thiermann H; Worek F
Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
[TBL] [Abstract][Full Text] [Related]
13. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
De Sarno P; Pomponi M; Giacobini E; Tang XC; Williams E
Neurochem Res; 1989 Oct; 14(10):971-7. PubMed ID: 2608162
[TBL] [Abstract][Full Text] [Related]
14. Protection of guinea pigs against soman poisoning by pretreatment with p-nitrophenyl phosphoramidates.
Langenberg JP; De Jong LP; Benschop HP
Toxicol Appl Pharmacol; 1996 Oct; 140(2):444-50. PubMed ID: 8887462
[TBL] [Abstract][Full Text] [Related]
15. Determination of anti-convulsant and life-preserving capacities of three types of auto-injector therapies against soman intoxication in rats.
Myhrer T; Enger S; Aas P
Drug Test Anal; 2013 Aug; 5(8):693-701. PubMed ID: 22977014
[TBL] [Abstract][Full Text] [Related]
16. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation.
Philippens IH; Vanwersch RA; Groen B; Olivier B; Bruijnzeel PL; Melchers BP
Toxicol Sci; 2000 Jan; 53(1):84-91. PubMed ID: 10653525
[TBL] [Abstract][Full Text] [Related]
17. The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-maze.
Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
Neurosci Lett; 1992 Sep; 144(1-2):79-83. PubMed ID: 1436716
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs.
Meshulam Y; Davidovici R; Wengier A; Levy A
J Appl Toxicol; 1995; 15(4):263-6. PubMed ID: 7594194
[TBL] [Abstract][Full Text] [Related]
19. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo.
Xia DY; Wang LX; Pei SQ
Fundam Appl Toxicol; 1981; 1(2):217-21. PubMed ID: 7184786
[TBL] [Abstract][Full Text] [Related]
20. Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro.
Herkert NM; Schulz S; Wille T; Thiermann H; Hatz RA; Worek F
Toxicol Appl Pharmacol; 2011 May; 253(1):7-13. PubMed ID: 21402092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
